125 related articles for article (PubMed ID: 16569446)
1. Progressive deterioration of reaction time performance and choreiform symptoms in a new Huntington's disease transgenic ratmodel.
Cao C; Temel Y; Blokland A; Ozen H; Steinbusch HW; Vlamings R; Nguyen HP; von Hörsten S; Schmitz C; Visser-Vandewalle V
Behav Brain Res; 2006 Jun; 170(2):257-61. PubMed ID: 16569446
[TBL] [Abstract][Full Text] [Related]
2. Normal sensitivity to excitotoxicity in a transgenic Huntington's disease rat.
Winkler C; Gil JM; Araújo IM; Riess O; Skripuletz T; von Hörsten S; Petersén A
Brain Res Bull; 2006 Apr; 69(3):306-10. PubMed ID: 16564426
[TBL] [Abstract][Full Text] [Related]
3. Behavioral abnormalities precede neuropathological markers in rats transgenic for Huntington's disease.
Nguyen HP; Kobbe P; Rahne H; Wörpel T; Jäger B; Stephan M; Pabst R; Holzmann C; Riess O; Korr H; Kántor O; Petrasch-Parwez E; Wetzel R; Osmand A; von Hörsten S
Hum Mol Genet; 2006 Nov; 15(21):3177-94. PubMed ID: 16984963
[TBL] [Abstract][Full Text] [Related]
4. Motor and non-motor behaviour in experimental Huntington's disease.
Zeef DH; Vlamings R; Lim LW; Tan S; Janssen ML; Jahanshahi A; Hoogland G; Prickaerts J; Steinbusch HW; Temel Y
Behav Brain Res; 2012 Jan; 226(2):435-9. PubMed ID: 22001615
[TBL] [Abstract][Full Text] [Related]
5. Increased numbers of motor activity peaks during light cycle are associated with reductions in adrenergic alpha(2)-receptor levels in a transgenic Huntington's disease rat model.
Bode FJ; Stephan M; Wiehager S; Nguyen HP; Björkqvist M; von Hörsten S; Bauer A; Petersén A
Behav Brain Res; 2009 Dec; 205(1):175-82. PubMed ID: 19573560
[TBL] [Abstract][Full Text] [Related]
6. Altered emotional and motivational processing in the transgenic rat model for Huntington's disease.
Faure A; Höhn S; Von Hörsten S; Delatour B; Raber K; Le Blanc P; Desvignes N; Doyère V; El Massioui N
Neurobiol Learn Mem; 2011 Jan; 95(1):92-101. PubMed ID: 21111837
[TBL] [Abstract][Full Text] [Related]
7. Time-lapse analysis of aggregate formation in an inducible PC12 cell model of Huntington's disease reveals time-dependent aggregate formation that transiently delays cell death.
Gong B; Lim MC; Wanderer J; Wyttenbach A; Morton AJ
Brain Res Bull; 2008 Jan; 75(1):146-57. PubMed ID: 18158109
[TBL] [Abstract][Full Text] [Related]
8. Selective striatal neuron loss and alterations in behavior correlate with impaired striatal function in Huntington's disease transgenic rats.
Kántor O; Temel Y; Holzmann C; Raber K; Nguyen HP; Cao C; Türkoglu HO; Rutten BP; Visser-Vandewalle V; Steinbusch HW; Blokland A; Korr H; Riess O; von Hörsten S; Schmitz C
Neurobiol Dis; 2006 Jun; 22(3):538-47. PubMed ID: 16480885
[TBL] [Abstract][Full Text] [Related]
9. Progressive behavioural changes in the spatial open-field in the quinolinic acid rat model of Huntington's disease.
Scattoni ML; Valanzano A; Popoli P; Pezzola A; Reggio R; Calamandrei G
Behav Brain Res; 2004 Jul; 152(2):375-83. PubMed ID: 15196806
[TBL] [Abstract][Full Text] [Related]
10. Animal models of Huntington's disease.
Gárdián G
Ideggyogy Sz; 2006 Nov; 59(11-12):396-9. PubMed ID: 17203874
[TBL] [Abstract][Full Text] [Related]
11. Coexistence of Gait Disturbances and Chorea in Experimental Huntington's Disease.
Casaca-Carreira J; Temel Y; van Zelst M; Jahanshahi A
Behav Neurol; 2015; 2015():970204. PubMed ID: 26063966
[TBL] [Abstract][Full Text] [Related]
12. Calcineurin inhibitors cause an acceleration of the neurological phenotype in a mouse transgenic for the human Huntington's disease mutation.
Hernández-Espinosa D; Morton AJ
Brain Res Bull; 2006 May; 69(6):669-79. PubMed ID: 16716837
[TBL] [Abstract][Full Text] [Related]
13. Huntington's Disease-like 2 (HDL2) in North America and Japan.
Margolis RL; Holmes SE; Rosenblatt A; Gourley L; O'Hearn E; Ross CA; Seltzer WK; Walker RH; Ashizawa T; Rasmussen A; Hayden M; Almqvist EW; Harris J; Fahn S; MacDonald ME; Mysore J; Shimohata T; Tsuji S; Potter N; Nakaso K; Adachi Y; Nakashima K; Bird T; Krause A; Greenstein P
Ann Neurol; 2004 Nov; 56(5):670-4. PubMed ID: 15468075
[TBL] [Abstract][Full Text] [Related]
14. The relationship between CAG repeat length and clinical progression in Huntington's disease.
Ravina B; Romer M; Constantinescu R; Biglan K; Brocht A; Kieburtz K; Shoulson I; McDermott MP
Mov Disord; 2008 Jul; 23(9):1223-7. PubMed ID: 18512767
[TBL] [Abstract][Full Text] [Related]
15. Oculomotor deficits indicate the progression of Huntington's disease.
Hicks SL; Robert MP; Golding CV; Tabrizi SJ; Kennard C
Prog Brain Res; 2008; 171():555-8. PubMed ID: 18718352
[TBL] [Abstract][Full Text] [Related]
16. Behavioral and in vivo electrophysiological evidence for presymptomatic alteration of prefrontostriatal processing in the transgenic rat model for huntington disease.
Höhn S; Dallérac G; Faure A; Urbach YK; Nguyen HP; Riess O; von Hörsten S; Le Blanc P; Desvignes N; El Massioui N; Brown BL; Doyère V
J Neurosci; 2011 Jun; 31(24):8986-97. PubMed ID: 21677182
[TBL] [Abstract][Full Text] [Related]
17. Phosphodiesterase type IV inhibition prevents sequestration of CREB binding protein, protects striatal parvalbumin interneurons and rescues motor deficits in the R6/2 mouse model of Huntington's disease.
Giampà C; Middei S; Patassini S; Borreca A; Marullo F; Laurenti D; Bernardi G; Ammassari-Teule M; Fusco FR
Eur J Neurosci; 2009 Mar; 29(5):902-10. PubMed ID: 19291221
[TBL] [Abstract][Full Text] [Related]
18. Monozygotic twins suffering from Huntington's disease show different cognitive and behavioural symptoms.
Gómez-Esteban JC; Lezcano E; Zarranz JJ; Velasco F; Garamendi I; Pérez T; Tijero B
Eur Neurol; 2007; 57(1):26-30. PubMed ID: 17108691
[TBL] [Abstract][Full Text] [Related]
19. Re: Autopsy-proven Huntington's disease with 29 trinucleotide repeats.
Reynolds N
Mov Disord; 2008 Sep; 23(12):1795-6; author reply 1793. PubMed ID: 18548610
[No Abstract] [Full Text] [Related]
20. Sex differences in a transgenic rat model of Huntington's disease: decreased 17beta-estradiol levels correlate with reduced numbers of DARPP32+ neurons in males.
Bode FJ; Stephan M; Suhling H; Pabst R; Straub RH; Raber KA; Bonin M; Nguyen HP; Riess O; Bauer A; Sjoberg C; Petersén A; von Hörsten S
Hum Mol Genet; 2008 Sep; 17(17):2595-609. PubMed ID: 18502785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
